2- Tuesday Pharmacy Practice News – 27th July

1 – Integrated Health-System Specialty Pharmacy Care Model Associated With Lower Oncology Medical Expenses

• Research presented at the 2021 American Society of Health-System Pharmacists (ASHP) Specialty Pharmacy Conference suggests overall medical expenses for oncology patients were significantly improved by using an integrated health-system specialty pharmacy (HSSP) care model.
• This model was associated with a $911 mean per member per month (PMPM, P<.05) decrease in total medical expense.
• According to the investigators, this is due to reduced hospital outpatient visits, free standing physician office visits, and emergency department (ED) visits.

Source: Pharmacy Times

2 – Study: COVID-19 Vaccine Efficacy, Awareness Important to Convert Hesitant Individuals

• It is critical to continue to raise awareness regarding the efficacy of COVID-19 vaccines, specifically with favorable comparisons to other well-established vaccines.
• The researchers found that adults who were unsure about receiving the COVID-19 vaccine and who were given more information about the vaccine’s efficacy scored 20% higher on a measure of willingness to be vaccinated versus others who received no information.
• Further, receptivity improved and increased almost as double among survey respondents who were given information about how COVID-19 vaccines perform compared to the flu vaccine.

Source: Pharmacy Times

3 – Study: Testosterone Supplementation Reduces Heart Attack, Stroke Risk

• Therapy with testosterone supplementation significantly reduces heart attacks and strokes among men with unnaturally low levels of the hormone, according to new research presented at the European Association of Urology congress.
• Researchers conducted a 10-year study with more than 800 men from Germany and Qatar with testosterone deficiency.
• Men under 55 years of age had a 25% lower risk of heart attack and stroke, whereas men over 60 had a 15% reduced risk with testosterone supplementation.

Source: Pharmacy Times

4- Strategies for Improving Adherence With Oral Oncolytics

• The use of oral oncolytics has become a common in cancer care with more than 115 FDA-approved therapies for managing malignancy. Adherence to these medications, however, can be challenging for patients.
• In a session of the virtual American Society of Health-System Pharmacists Specialty Pharmacy Conference, presenter Eve Segal, PharmD, BCOP, lead clinical pharmacist, University of Washington Medical Center/Seattle Cancer Care Alliance, discussed advantages to oral oncolytics, as well as a need for pharmacists to understand barriers to adherence faced by patients who are prescribed these medications.
• Segal also offered strategies for improving adherence for patients taking these medications.

Source: Pharmacy Times

5 – Adoption of Biosimilars in Health Systems Faces Challenges and a Promising Future

• Biosimilar agents are highly similar to biological reference products that have been approved by the FDA, but demonstrate no clinically meaningful safety, purity, and potency differences.
• The use of biosimilar medications is projected to increase over the next few years.
• In a session at the virtual Association of Health-System Pharmacists Specialty Conference, presenters provided an overview of biosimilar therapies, discussed a robust pipeline of biosimilar products, and offered strategies for the adoption of biosimilars in health systems.

Source: Pharmacy Times

6 – Study Finds Flu Shots Protect Against Some Severe COVID-19 Symptoms

• The flu vaccine may provide some protection against severe symptoms of COVID-19, with a new study finding lower intensive care unit (ICU) admissions, sepsis, and stroke rates.
• An analysis of patient data presented at the European Congress of Clinical Microbiology & Infectious Diseases found that the annual flu shot reduces the risk of stroke, sepsis, and deep vein thrombosis (DVT) in patients with COVID-19.
• Individuals with COVID-19 who had been vaccinated against the flu were also less likely to visit emergency departments (ED) and to be admitted to the ICU.

Source: Pharmacy Times

• Read more from FADIC Blog, with many articles with evidence based articles.
• Learn More Through FADIC® – Online Programs & Mini-Courses.
• Listen Now to FADIC Podcast focusing on varieties of pharmacist perspectives in specialties.
• Read More Now about FADIC Pharmacy Events to get more Experience.

Course Copyrights:

All Courses is meant for SINGLE user use only.
If more than one person acceced this course, they will be BLOCKED Forever.

Why FADIC 2020 Pharmacotherapy Daily News (FNN) ?

• It helps to keep up with the literature!
• Provide you with the Updated with the latest in your clinical practice. Wherever you are, and Whenever you need!
• Help you to share in the advance in clinical career. In addition to adding an impressive image to the pharmacists all-around!

Subscribe to FADIC 2021 Pharmacy Practice FNN E-News, for publication of:

Read & Download FNN Issue 8 of April 2020 FNN News